Indices, IPOs, and New Drug Approvals | BIOtechNow

< Back to Newsletter Archive

Indices, IPOs, and New Drug Approvals | BIOtechNow

We've changed. And not just our outside, our inside too.

BIO is proud to announce the redesign of our primary e-newsletter. The new Communiqué is a bi-weekly electronic publication replacing the monthly BIOtechNOW e-newsletter. Our new design and schedule will allow us to provide even more critical and timely information about the industry as well as insights and opinions from BIO staff and industry experts.

announcement

04.18.2012

BIOTECH INDUSTRY

Indices, IPOs, and New Drug Approvals

The Nasdaq Biotech Index (NBI) continued to outperform in March, maintaining its Year-to-Date (YTD) lead of 18% vs. 12% for the S&P 500...

Share:

Fox Trial Finder and You

The Michael J. Fox Foundation launched Fox Trial Finder, a new web tool that uses state-of-the art technology to connect potential study volunteers with the coordinators of clinical studies...

Share:

Industry Confidence

The industry's confidence remains high, with 78 percent of bioenergy executives reporting they feel more optimistic about their organization's prospects for growth...

Share:

2012 BIO INTERNATIONAL CONVENTION

Biotech IP and Tech Transfer Sessions

The 2012 BIO International Convention will feature an educational track devoted to Biotech Patenting and Tech Transfer...

Share:

BIOTECHNOLOGY INDUSTRY

Telling the Story of Biotechnology

Biotechnologists are in the tomorrow business. They strive to innovate, invent, and make progress...

Share:

2012 BIO INTERNATIONAL CONVENTION

Partnering Launches

It's here folks! The One-on-One Partnering™ System for this year's BIO Business Forum® and Exhibitor Partnering has officially launched...

Share:

Patented Drugs Save Us All Money

New patented drugs actually save the United States and its citizens lots of money...

Share:

OPRPHAN DISEASES

2012 Orphan Disease Forum

If all of the people with rare disease lived in one country, it would be the world's third most populous...

Share:

MassBioEd Innovative School of the Year

This year, MassBioEd granted the Innovative School of the Year award to Norton High School in Norton, MA...

Share:

Comments on FDA Draft Guidances on Biosimilars

BIO supports the FDA's ongoing implementation of a science-based pathway for the review and approval of biosimilars that protects patient safety and promotes continued innovation...

Share:

Anti-retroviral Treatment for HIV-infected Infants

It is important to identify and treat HIV-infected infants within the first year of life to prevent harm to the immune system and to enable normal neurological development...

Share:

Gene Therapy Helps Patients with Hemophilia

A single dose of an experimental gene therapy boosted production of a missing blood-clotting factor in people with hemophilia...

Share:

Fatty Liver Disease in Children

Results from a small pilot study using cysteamine in 11 children with NASH suggest that it improves liver enzymes by reducing toxins...

Share:

ALZHEIMER'S DISEASE

Blockade of Memory Genes May Occur Early in Alzheimer's

In mouse models of Alzheimer's disease, this epigenetic blockade and its effects on memory were treatable...

Share:

Breast Cancer Susceptibility Gene

Many breast cancer cases appear in families with a weak history of the disease...

Share:

RHEUMATOID ARTHRITIS

RA Drug Halts Organ Damage

A new study shows that Kineret, a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage...

Share:

2012 WORLD CONGRESS IN INDUSTRIAL BIOTECHNOLOGY

Investment Trends in Clean Tech

BIO announced the companies selected to present their development and business models to an elite audience of investors and analysts at BIO's 9th annual World Congress on Industrial Biotechnology...

Share:

2012 World Congress on Industrial Biotechnology

Execs From Coca Cola, United Airlines, Goodyear and Chrysler Among Speakers

Executives from brand-name consumer product companies will discuss the strategies for adoption of industrial biotech innovations in plenary and breakout sessions at BIO's 9th annual World Congress on Industrial Biotechnology...

Share:

ENERGY INDEPENDENCE

Farm Bill Energy Title Reauthorization

Farm Bill energy programs have helped innovative companies unlock private capital for construction of advanced biofuel biorefineries...

Share:

Advertisement

Conferences & Events

04.29.12

World Congress on Industrial Biotechnology & Bioprocessing

The World Congress on Industrial Biotechnology and Bioprocessing is the world's largest industrial biotechnology event…

06.18.12

2012 BIO International Convention

Thousands of companies from around the world and all industry segments will be at BIO, ready to build strategic partnerships…

09.12.12

BIO India International Conference

The BIO India International Conference brings together biotechnology and pharmaceutical companies from North America, Europe and Asia to meet and explore business opportunities with India's emerging biotech sector…

09.19.12

Livestock Biotech Summit

This unique conference offers a focus on genetic engineering of agricultural animals including benefits, research and development, regulatory system, and challenges…

10.24.12

BIO Convention in China

The BIO Convention in China brings together executives from biotechnology, pharmaceutical companies and investment firms from North America, Europe and Asia…

Advertisement

ON FACEBOOK.COM/IAMBIOTECH

Do you think this is truly possible: a cancer vaccine effective against most cancer and even really resistant and pervasive types, by 2020?

11 COMMENTED | 22 SHARED | JOIN

ON Twitter.COM/IAMBIOTECH

In an exciting breakthru UCLA scientists say they found a way to turn #stem cells into cells that fight #HIV http://bit.ly/HOM7gg

16 Tweets | JOIN

ON Linkedin.COM

What Recruiters Look at on Your Resume in 6 Seconds...

9 Comments | JOIN

Polls & Quizzes

How optimistic are you about the prospects for growth in the bioenergy industry?